Skip to main content
PMC home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2007 Aug;99(8):868–875.

Overcoming barriers to glycemic control in African Americans with type-2 diabetes: benefits of insulin therapy.

Merville C Marshall Jr 1
PMCID: PMC2574306  PMID: 17722663

Abstract

A disproportionate number of African-American men and women are affected by obesity and diabetes. The documented rate of poor glycemic control in the African-American population may contribute to the high rate of morbidity and mortality due to diabetes observed in these patients. Since the benefits of strict glycemic control have been demonstrated in multiple large trials, the aim of treatment should be to achieve the goals set forth by the American Diabetes Association. Insulin remains an essential therapeutic agent for helping patients achieve glycemic control and preventing long-term comorbidities. However, barriers to insulin therapy exist for both the physician and patient. Strategies to counter this resistance include identifying barriers to treatment, restoring the patient's sense of control, utilizing simple regimens, and reviewing the benefits of insulin and the risk of hypoglycemia. In treating African-American patients with diabetes, providers of various racial and ethnic backgrounds may maximize treatment efficacy by attempting to understand and practice culturally competent care.

Full text

PDF
868

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banerji M. A., Chaiken R. L., Huey H., Tuomi T., Norin A. J., Mackay I. R., Rowley M. J., Zimmet P. Z., Lebovitz H. E. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes. 1994 Jun;43(6):741–745. doi: 10.2337/diab.43.6.741. [DOI] [PubMed] [Google Scholar]
  2. Banerji M. A., Chaiken R. L., Lebovitz H. E. Long-term normoglycemic remission in black newly diagnosed NIDDM subjects. Diabetes. 1996 Mar;45(3):337–341. doi: 10.2337/diab.45.3.337. [DOI] [PubMed] [Google Scholar]
  3. Bashoff E. C., Beaser R. S. Insulin therapy and the reluctant patient. Overcoming obstacles to success. Postgrad Med. 1995 Feb;97(2):86-90, 93-6. [PubMed] [Google Scholar]
  4. Boltri John M., Okosun Ike S., Davis-Smith Monique, Vogel Robert L. Hemoglobin A1c levels in diagnosed and undiagnosed black, Hispanic, and white persons with diabetes: results from NHANES 1999-2000. Ethn Dis. 2005 Autumn;15(4):562–567. [PubMed] [Google Scholar]
  5. Boyle J. P., Honeycutt A. A., Narayan K. M., Hoerger T. J., Geiss L. S., Chen H., Thompson T. J. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care. 2001 Nov;24(11):1936–1940. doi: 10.2337/diacare.24.11.1936. [DOI] [PubMed] [Google Scholar]
  6. Centers for Disease Control and Prevention (CDC) Lower extremity disease among persons aged > or =40 years with and without diabetes--United States, 1999-2002. MMWR Morb Mortal Wkly Rep. 2005 Nov 18;54(45):1158–1160. [PubMed] [Google Scholar]
  7. Cook C. B., Ziemer D. C., El-Kebbi I. M., Gallina D. L., Dunbar V. G., Ernst K. L., Phillips L. S. Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes. Diabetes Care. 1999 Sep;22(9):1494–1500. doi: 10.2337/diacare.22.9.1494. [DOI] [PubMed] [Google Scholar]
  8. Cook Michael N., Girman Cynthia J., Stein Peter P., Alexander Charles M., Holman Rury R. Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes. Diabetes Care. 2005 May;28(5):995–1000. doi: 10.2337/diacare.28.5.995. [DOI] [PubMed] [Google Scholar]
  9. Davidson Mayer B. Effect of nurse-directed diabetes care in a minority population. Diabetes Care. 2003 Aug;26(8):2281–2287. doi: 10.2337/diacare.26.8.2281. [DOI] [PubMed] [Google Scholar]
  10. Davies M., Dixon S., Currie C. J., Davis R. E., Peters J. R. Evaluation of a hospital diabetes specialist nursing service: a randomized controlled trial. Diabet Med. 2001 Apr;18(4):301–307. doi: 10.1046/j.1464-5491.2001.00470.x. [DOI] [PubMed] [Google Scholar]
  11. Emanuele Nicholas, Sacks Jerome, Klein Ronald, Reda Domenic, Anderson Robert, Duckworth William, Abraira Carlos, Veterans Affairs Diabetes Trial Group Ethnicity, race, and baseline retinopathy correlates in the veterans affairs diabetes trial. Diabetes Care. 2005 Aug;28(8):1954–1958. doi: 10.2337/diacare.28.8.1954. [DOI] [PubMed] [Google Scholar]
  12. Fanelli Carmine G., Pampanelli Simone, Porcellati Francesca, Rossetti Paolo, Brunetti Paolo, Bolli Geremia B. Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial. Ann Intern Med. 2002 Apr 2;136(7):504–514. doi: 10.7326/0003-4819-136-7-200204020-00007. [DOI] [PubMed] [Google Scholar]
  13. Feddersen E., Lockwood D. H. An inpatient diabetes educator's impact on length of hospital stay. Diabetes Educ. 1994 Mar-Apr;20(2):125–128. doi: 10.1177/014572179402000207. [DOI] [PubMed] [Google Scholar]
  14. Flegal Katherine M., Carroll Margaret D., Ogden Cynthia L., Johnson Clifford L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002 Oct 9;288(14):1723–1727. doi: 10.1001/jama.288.14.1723. [DOI] [PubMed] [Google Scholar]
  15. Graham Garth N., Leath Brenda, Payne Kermit, Guendelman Maya, Reynolds Gladys, Kim Soo, James Barbara, Ware Donald, Hunter Mildred, Burwell Audrey. Perceived versus actual risk for hypertension and diabetes in the African American community. Health Promot Pract. 2006 Jan;7(1):34–46. doi: 10.1177/1524839905283891. [DOI] [PubMed] [Google Scholar]
  16. Grant Richard W., Buse John B., Meigs James B., University HealthSystem Consortium (UHC) Diabetes Benchmarking Project Team Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabetes Care. 2005 Feb;28(2):337–442. doi: 10.2337/diacare.28.2.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Groman Rachel, Ginsburg Jack, American College of Physicians Racial and ethnic disparities in health care: a position paper of the American College of Physicians. Ann Intern Med. 2004 Aug 3;141(3):226–232. doi: 10.7326/0003-4819-141-3-200408030-00015. [DOI] [PubMed] [Google Scholar]
  18. Hedley Allison A., Ogden Cynthia L., Johnson Clifford L., Carroll Margaret D., Curtin Lester R., Flegal Katherine M. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004 Jun 16;291(23):2847–2850. doi: 10.1001/jama.291.23.2847. [DOI] [PubMed] [Google Scholar]
  19. Heine Robert J., Van Gaal Luc F., Johns Don, Mihm Michael J., Widel Mario H., Brodows Robert G., GWAA Study Group Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial. Ann Intern Med. 2005 Oct 18;143(8):559–569. doi: 10.7326/0003-4819-143-8-200510180-00006. [DOI] [PubMed] [Google Scholar]
  20. Hermansen Kjeld, Davies Melanie, Derezinski Taudeusz, Martinez Ravn Gabrielle, Clauson Per, Home Philip. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetes Care. 2006 Jun;29(6):1269–1274. doi: 10.2337/dc05-1365. [DOI] [PubMed] [Google Scholar]
  21. Hunt L. M., Valenzuela M. A., Pugh J. A. NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance. Diabetes Care. 1997 Mar;20(3):292–298. doi: 10.2337/diacare.20.3.292. [DOI] [PubMed] [Google Scholar]
  22. Ilkova H., Glaser B., Tunçkale A., Bagriaçik N., Cerasi E. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care. 1997 Sep;20(9):1353–1356. doi: 10.2337/diacare.20.9.1353. [DOI] [PubMed] [Google Scholar]
  23. Jacobs Elizabeth A., Rolle Italia, Ferrans Carol Estwing, Whitaker Eric E., Warnecke Richard B. Understanding African Americans' views of the trustworthiness of physicians. J Gen Intern Med. 2006 Jun;21(6):642–647. doi: 10.1111/j.1525-1497.2006.00485.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jenkins Carolyn, McNary Sara, Carlson Barbara A., King Marilyn Givens, Hossler Charles L., Magwood Gayenell, Zheng Deyi, Hendrix Katharine, Beck Lorna Shelton, Linnen Florene. Reducing disparities for African Americans with diabetes: progress made by the REACH 2010 Charleston and Georgetown Diabetes Coalition. Public Health Rep. 2004 May-Jun;119(3):322–330. doi: 10.1016/j.phr.2004.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kayashima T., Yamaguchi K., Konno Y., Nanimatsu H., Aragaki S., Shichiri M. Effects of early introduction of intensive insulin therapy on the clinical course in non-obese NIDDM patients. Diabetes Res Clin Pract. 1995 May;28(2):119–125. doi: 10.1016/0168-8227(95)01066-m. [DOI] [PubMed] [Google Scholar]
  26. Lipton Rebecca, Drum Melinda, Burnet Deborah, Mencarini Maureen, Cooper Andrew, Rich Barry. Self-reported social class, self-management behaviors, and the effect of diabetes mellitus in urban, minority young people and their families. Arch Pediatr Adolesc Med. 2003 Sep;157(9):919–925. doi: 10.1001/archpedi.157.9.919. [DOI] [PubMed] [Google Scholar]
  27. Marshall M. C., Jr Diabetes in African Americans. Postgrad Med J. 2005 Dec;81(962):734–740. doi: 10.1136/pgmj.2004.028274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. McFarlane S. I., Chaiken R. L., Hirsch S., Harrington P., Lebovitz H. E., Banerji M. A. Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function. Diabet Med. 2001 Jan;18(1):10–16. doi: 10.1046/j.1464-5491.2001.00395.x. [DOI] [PubMed] [Google Scholar]
  29. Monnier Louis, Lapinski Hélène, Colette Claude. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care. 2003 Mar;26(3):881–885. doi: 10.2337/diacare.26.3.881. [DOI] [PubMed] [Google Scholar]
  30. Murphy S. L. Deaths: final data for 1998. Natl Vital Stat Rep. 2000 Jul 24;48(11):1–105. [PubMed] [Google Scholar]
  31. Nathan David M., Cleary Patricia A., Backlund Jye-Yu C., Genuth Saul M., Lachin John M., Orchard Trevor J., Raskin Philip, Zinman Bernard, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005 Dec 22;353(25):2643–2653. doi: 10.1056/NEJMoa052187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Phillips Lawrence S., Ziemer David C., Doyle Joyce P., Barnes Catherine S., Kolm Paul, Branch William T., Caudle Jane M., Cook Curtiss B., Dunbar Virginia G., El-Kebbi Imad M. An endocrinologist-supported intervention aimed at providers improves diabetes management in a primary care site: improving primary care of African Americans with diabetes (IPCAAD) 7. Diabetes Care. 2005 Oct;28(10):2352–2360. doi: 10.2337/diacare.28.10.2352. [DOI] [PubMed] [Google Scholar]
  33. Raskin Philip, Allen Elsie, Hollander Priscilla, Lewin Andrew, Gabbay Robert A., Hu Peter, Bode Bruce, Garber Alan, INITIATE Study Group Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care. 2005 Feb;28(2):260–265. doi: 10.2337/diacare.28.2.260. [DOI] [PubMed] [Google Scholar]
  34. Raslová K., Bogoev M., Raz I., Leth G., Gall M-A, Hâncu N. Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes. Diabetes Res Clin Pract. 2004 Nov;66(2):193–201. doi: 10.1016/j.diabres.2004.03.003. [DOI] [PubMed] [Google Scholar]
  35. Riddle Matthew C., Rosenstock Julio, Gerich John, Insulin Glargine 4002 Study Investigators The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003 Nov;26(11):3080–3086. doi: 10.2337/diacare.26.11.3080. [DOI] [PubMed] [Google Scholar]
  36. Rudolf Paul, Bartelme Amanda, Center for Insulin-Dependent Diabetes Access' Blue Ribbon Panel A strategic action plan for achieving uncompromising "treat to target" in individuals with insulin-dependent diabetes: a report by the Center for Insulin-Dependent Diabetes Access' Blue Ribbon Panel. Diabetes Technol Ther. 2005 Oct;7(5):755–767. doi: 10.1089/dia.2005.7.755. [DOI] [PubMed] [Google Scholar]
  37. Saydah Sharon H., Fradkin Judith, Cowie Catherine C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004 Jan 21;291(3):335–342. doi: 10.1001/jama.291.3.335. [DOI] [PubMed] [Google Scholar]
  38. Schillinger Dean, Grumbach Kevin, Piette John, Wang Frances, Osmond Dennis, Daher Carolyn, Palacios Jorge, Sullivan Gabriela Diaz, Bindman Andrew B. Association of health literacy with diabetes outcomes. JAMA. 2002 Jul 24;288(4):475–482. doi: 10.1001/jama.288.4.475. [DOI] [PubMed] [Google Scholar]
  39. Standl E., Maxeiner S., Raptis S., HOE901/4009 Study Group Once-daily insulin glargine administration in the morning compared to bedtime in combination with morning glimepiride in patients with type 2 diabetes: an assessment of treatment flexibility. Horm Metab Res. 2006 Mar;38(3):172–177. doi: 10.1055/s-2006-925222. [DOI] [PubMed] [Google Scholar]
  40. Two Feathers Jacqueline, Kieffer Edith C., Palmisano Gloria, Anderson Mike, Sinco Brandy, Janz Nancy, Heisler Michele, Spencer Mike, Guzman Ricardo, Thompson Janice. Racial and Ethnic Approaches to Community Health (REACH) Detroit partnership: improving diabetes-related outcomes among African American and Latino adults. Am J Public Health. 2005 Jul 28;95(9):1552–1560. doi: 10.2105/AJPH.2005.066134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Umpierrez G. E., Casals M. M., Gebhart S. P., Mixon P. S., Clark W. S., Phillips L. S. Diabetic ketoacidosis in obese African-Americans. Diabetes. 1995 Jul;44(7):790–795. doi: 10.2337/diab.44.7.790. [DOI] [PubMed] [Google Scholar]
  42. Umpierrez G. E., Kelly J. P., Navarrete J. E., Casals M. M., Kitabchi A. E. Hyperglycemic crises in urban blacks. Arch Intern Med. 1997 Mar 24;157(6):669–675. [PubMed] [Google Scholar]
  43. Wright Alex, Burden A. C. Felix, Paisey Richard B., Cull Carole A., Holman Rury R., U.K. Prospective Diabetes Study Group Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care. 2002 Feb;25(2):330–336. doi: 10.2337/diacare.25.2.330. [DOI] [PubMed] [Google Scholar]
  44. Ziemer David C., Doyle Joyce P., Barnes Catherine S., Branch William T., Jr, Cook Curtiss B., El-Kebbi Imad M., Gallina Daniel L., Kolm Paul, Rhee Mary K., Phillips Lawrence S. An intervention to overcome clinical inertia and improve diabetes mellitus control in a primary care setting: Improving Primary Care of African Americans with Diabetes (IPCAAD) 8. Arch Intern Med. 2006 Mar 13;166(5):507–513. doi: 10.1001/archinte.166.5.507. [DOI] [PubMed] [Google Scholar]
  45. Ziemer David C., Miller Christopher D., Rhee Mary K., Doyle Joyce P., Watkins Clyde, Jr, Cook Curtiss B., Gallina Daniel L., El-Kebbi Imad M., Barnes Catherine S., Dunbar Virginia G. Clinical inertia contributes to poor diabetes control in a primary care setting. Diabetes Educ. 2005 Jul-Aug;31(4):564–571. doi: 10.1177/0145721705279050. [DOI] [PubMed] [Google Scholar]
  46. de Groot Mary, Welch Garry, Buckland Golden T., 3rd, Fergus Mona, Ruggiero Laurie, Chipkin Stuart R. Cultural orientation and diabetes self-care in low-income African Americans with type 2 diabetes mellitus. Ethn Dis. 2003 Winter;13(1):6–14. [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES